The angiogenic properties of VEGF are mediated through the binding of VEGF to its receptor VEGFR2. The VEGF/VEGFR interface is constituted by a discontinuous binding region distributed on both VEGF monomers. We attempted to reproduce this discontinuous binding site by covalently linking into a single molecular entity two VEGF segments involved in receptor recognition. We designed and synthesized by chemical ligation a set of peptides differing in length and flexibility of the molecular linker joining the two VEGF segments. The biological activity of the peptides was characterized in vitro and in vivo showing a VEGF-like activity. The most biologically active mini-VEGF was further analyzed by NMR to determine the atomic details of its intera...
Pharmacological strategies aimed at preventing cancer growth are in most cases paralleled by diagnos...
International audienceAngiogenesis is the development of a novel vascular network from a pre-existin...
Tumor angiogenesis, essential for cancer development, is regulated mainly by vascular endothelial gr...
The angiogenic properties of VEGF are mediated through the binding of VEGF to its receptor VEGFR2. T...
The angiogenic properties of VEGF are mediated through the binding of VEGF to its receptor VEGFR2. T...
Modulating angiogenesis is an attractive goal because many pathological conditions depend on the gro...
Modulating angiogenesis is an attractive goal because many pathological conditions depend on the gro...
International audiencePhysiological and pathological angiogenesis is mainly regulated by the binding...
The interaction between vascular endothelial growth factor (VEGF) and its receptors (VEGFR) has impo...
VEGF receptors have been the target of intense research aimed to develop molecules able to inhibit o...
Angiogenesis is mainly regulated by the vascular endothelial growth factor (VEGF), a mitogen specifi...
VEGF receptors have been the target of intense research aimed to develop molecules able to inhibit o...
The interaction between vascular endothelial growth factor (VEGF) and its receptors (VEGFR) has impo...
Tumor angiogenesis, essential for cancer development, is regulated mainly by vascular endothelial gr...
Pharmacological strategies aimed at preventing cancer growth are in most cases paralleled by diagnos...
International audienceAngiogenesis is the development of a novel vascular network from a pre-existin...
Tumor angiogenesis, essential for cancer development, is regulated mainly by vascular endothelial gr...
The angiogenic properties of VEGF are mediated through the binding of VEGF to its receptor VEGFR2. T...
The angiogenic properties of VEGF are mediated through the binding of VEGF to its receptor VEGFR2. T...
Modulating angiogenesis is an attractive goal because many pathological conditions depend on the gro...
Modulating angiogenesis is an attractive goal because many pathological conditions depend on the gro...
International audiencePhysiological and pathological angiogenesis is mainly regulated by the binding...
The interaction between vascular endothelial growth factor (VEGF) and its receptors (VEGFR) has impo...
VEGF receptors have been the target of intense research aimed to develop molecules able to inhibit o...
Angiogenesis is mainly regulated by the vascular endothelial growth factor (VEGF), a mitogen specifi...
VEGF receptors have been the target of intense research aimed to develop molecules able to inhibit o...
The interaction between vascular endothelial growth factor (VEGF) and its receptors (VEGFR) has impo...
Tumor angiogenesis, essential for cancer development, is regulated mainly by vascular endothelial gr...
Pharmacological strategies aimed at preventing cancer growth are in most cases paralleled by diagnos...
International audienceAngiogenesis is the development of a novel vascular network from a pre-existin...
Tumor angiogenesis, essential for cancer development, is regulated mainly by vascular endothelial gr...